Treating epidermlyosis bullosa with thymosin Beta-4
通过给予一种螯合肌动蛋白的多肽,例如胸腺素β4、胸腺素β4的同种异型体或氧化的胸腺素β4,治疗和预防与大疱性表皮松解症相关的水泡、疮伤或皮肤恶变。 Blister, sores or skin degradation associated with Epidermolysis Bullosa is treated or prevented by administration of a actin-sequestering peptide such as Thymosin beta 4, an isoform of Thymosin beta 4 or oxidized Thymosin bet...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
07.07.2004
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | 通过给予一种螯合肌动蛋白的多肽,例如胸腺素β4、胸腺素β4的同种异型体或氧化的胸腺素β4,治疗和预防与大疱性表皮松解症相关的水泡、疮伤或皮肤恶变。
Blister, sores or skin degradation associated with Epidermolysis Bullosa is treated or prevented by administration of a actin-sequestering peptide such as Thymosin beta 4, an isoform of Thymosin beta 4 or oxidized Thymosin beta 4. |
---|---|
Bibliography: | Application Number: CN20028010095 |